Fedorenko Denis, Doctor.

The Leading Hematologist of Russia, Doctor of Medical Sciences,
Professor of the Department of Hematology and Cellular Therapy. A.A. Maksimova
We carefully weigh risk and benefits of transplantation in every individual case.
Detailed examination always precedes the final decision about the appropriateness of high-dose immunosuppressive therapy with hematopoietic stem cell transplantation.
PROFESSIONAL EXPIRIENCE
1993-1999
Military Medical Academy named after S.M. Kirov.
1999-2000
Internship on the specialty "Internal Diseases".
2001-2004
Adjuncture at the Department of Hematology and Clinical Immunology of the Military Medical Academy.
Professor of Medical Science
Author of more than 200 scientific papers and 1 invention (patent No. 2600160
"A method for treating multiple sclerosis and other systemic autoimmune diseases"
The certificate for the specialty "Hematology"
No. 0377240019765, is valid until November 15, 2019.
Treatment coordinator
Coordinator of a program of high-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis and other systemic autoimmune diseases.
Treatment program "Quality of Life"
A participant in international programs for the study of quality of life and symptoms in oncohematological patients on the background of various treatment programs.
Efficacy and toxicity study of high-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis and other systemic autoimmune diseases.
Scientific researches
Studying of the features of mobilization and conditioning using high-dose immunosuppressive therapy with autologous transplantation of hematopoietic stem cells in patients with multiple sclerosis and other systemic autoimmune diseases
Scientific researches
Studying of a quality of life parameters using high-dose immunosuppressive therapy with autologous transplantation of hematopoietic stem cells in patients with multiple sclerosis.
Candidate dissertation
"Syndrome of generalized weakness in patients with certain systemic diseases of connective tissue."
Doctoral dissertation:
"Principles of assessing the effectiveness of autologous transplantation of hematopoietic stem cells in patients with lymphomas and multiple sclerosis."
ASH
Member of the American Association of Hematology
EHA
Member of the European Hematology Association

ISQOL
Member of the International Society for the Study of Quality of Life
The main directions of medical work:
  • Treatment of diseases of the blood system with the use of modern technologies, incl. bone marrow transplantation / peripheral hematopoietic stem cells, high-dose chemotherapy, immunotherapy of oncohematological diseases (lymphomas, leukemia)

  • High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis and other systemic autoimmune diseases

  • Risk-adapted therapy of leukemia and lymphoma